BioCatalyst

QNRX — Quoin Pharmaceuticals Ltd. catalysts

3 verified catalyst event(s) for Quoin Pharmaceuticals Ltd. (ticker QNRX). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-12-30 — Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-30
in 2mo
ESTIMATED
 READOUT
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherto
Phase 2/3 · Netherton Syndrome
 QNRX Quoin Pharmaceuticals Ltd. QRX003, 4% Lotion ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2026-12-30
in 2mo
ESTIMATED
 READOUT
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/3 · Netherton Syndrome
 QNRX Quoin Pharmaceuticals Ltd. QRX003, 4% Lotion ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-01-31
in 3mo
ESTIMATED
 READOUT
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/3 · Netherton Syndrome
 QNRX Quoin Pharmaceuticals Ltd. QRX003 ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.